INUS
Straddle Chart

Markets / Mutual funds / Sectoral / Thematic

Mutual fundsSIF

LIC MF Healthcare Fund - Direct Plan - Growth

NAVs of 8 Nov 2026

LIC Mutual Fund · Equity fund · Direct plan · Growth

Sectoral / ThematicDirect · GrowthRisk: Very High
NAV · 6 Nov 2026
₹37.4275 ▲ 0.20%
LIC Mutual Fund
Fund size₹99.41 crJuly - September 2026
1-month range₹34.24 – 37.43
1 year+14.31%rank 32 of 204
Expense ratio1.42%direct plan, a year
5 years–a year

What the fund does

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.

BenchmarkBSE Healthcare - TRI
Fund houseLIC Mutual Fund
Fund managersFM 1: Mr. Sudhanshu AsthanaFM 2: Mr. Dhaval Sangoi

NAV history

343638 2026-08-122026-08-252026-09-072026-09-212026-10-052026-10-162026-10-30

Returns

1 week
+2.89%avg 5.2%
1 month
+2.81%avg 3.0%
3 months
-0.44%avg -1.6%
6 months
+9.93%avg 3.7%
This year
+17.12%avg 4.5%
1 year
+14.31%avg 5.5% · #32/204
3 years (a year)
+22.81%avg 15.3% · #10/127

Bars: this plan; the thin mark is the Sectoral / Thematic average (direct plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.

Monthly returns (%)

YearJanFebMarAprMayJunJulAugSepOctNovDec
2024-0.2
2025-5.0-8.9+8.8-0.8+0.5+2.8+3.9-3.1-0.7+3.7+0.4-2.6
2026-5.8+4.9-4.6+7.5+4.6+4.0+4.3+4.8-5.2-0.3+2.9

Each month's change in NAV (the current month to the latest NAV).

What if you had invested?

Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.

Portfolio as on 31 Oct 2026

Stocks held2729 lines in all
Top 10 stocks55.5%of the fund
Equity96.2%stocks and equity derivatives
Debt & cash3.8%everything else

Where the money is

Equity 96.2%Cash & others 3.8%

Sectors (stocks held)

Pharmaceuticals & Biotechnology
57.9%
Healthcare Services
34.1%
Chemicals & Petrochemicals
4.2%

Changes since 30 Sept 2026

Share of fund31 Oct 202630 Sept 2026Change
Stocks held96.2%97.5%-1.33
Short positions0.0%-0.1%+0.10
Cash & others3.8%2.5%+1.34
Top 10 stocks55.5%60.2%-4.69
Number of stocks2725+2
New stocks 3
  • Yatharth Hospital&Trauma Care Serv Ltd.2.16%
  • Rainbow Children's Medicare Ltd.2.12%
  • Gujarat Fluorochemicals Ltd.1.54%
Stocks sold off 1
  • Artemis Medicare Services Ltd.was 1.26%
Bought more 5
  • Piramal Pharma Ltd.+1.54
  • Nephrocare Health Services Ltd.+1.09
  • Apollo Hospitals Enterprise Ltd.+0.38
  • Metropolis Healthcare Ltd.+0.38
  • Gland Pharma Ltd.+0.32
Cut back 7
  • Global Health Ltd.-2.41
  • Navin Fluorine International Ltd.-2.28
  • Divi's Laboratories Ltd.-1.98
  • Zydus Lifesciences Ltd.-1.74
  • Sun Pharmaceutical Industries Ltd.-0.94
  • Neuland Laboratories Ltd.-0.31
  • Mankind Pharma Ltd.-0.27

Change is in percentage points. Bought more and cut back list stocks whose share of the fund moved by at least 0.25 points. A share can also move because the price changed, not only because the fund traded.

Stocks held 27

HoldingSector / type% of fund
Sun Pharmaceutical Industries Ltd.
INE044A01036		Pharmaceuticals & Biotechnology8.65%
Divi's Laboratories Ltd.
INE361B01024		Pharmaceuticals & Biotechnology7.09%
Apollo Hospitals Enterprise Ltd.
INE437A01024		Healthcare Services6.13%
Torrent Pharmaceuticals Ltd.
INE685A01028		Pharmaceuticals & Biotechnology5.97%
Neuland Laboratories Ltd.
INE794A01010		Pharmaceuticals & Biotechnology5.83%
Aurobindo Pharma Ltd.
INE406A01037		Pharmaceuticals & Biotechnology5.41%
Aster DM Quality Care Ltd.
INE914M01019		Healthcare Services4.64%
Nephrocare Health Services Ltd.
INE428V01029		Healthcare Services4.14%
Fortis Healthcare Ltd.
INE061F01013		Healthcare Services3.87%
Metropolis Healthcare Ltd.
INE112L01020		Healthcare Services3.73%
Gland Pharma Ltd.
INE068V01023		Pharmaceuticals & Biotechnology3.52%
Zydus Lifesciences Ltd.
INE010B01027		Pharmaceuticals & Biotechnology3.23%
Cohance Lifesciences Ltd.
INE03QK01018		Pharmaceuticals & Biotechnology3.04%
Piramal Pharma Ltd.
INE0DK501011		Pharmaceuticals & Biotechnology2.97%
Max Healthcare Institute Ltd.
INE027H01010		Healthcare Services2.85%
Mankind Pharma Ltd.
INE634S01028		Pharmaceuticals & Biotechnology2.84%
Navin Fluorine International Ltd.
INE048G01026		Chemicals & Petrochemicals2.70%
Dr Agarwal's Health Care Ltd.
INE943P01029		Healthcare Services2.69%
Onesource Specialty Pharma Ltd.
INE013P01021		Pharmaceuticals & Biotechnology2.43%
Glenmark Pharmaceuticals Ltd.
INE935A01035		Pharmaceuticals & Biotechnology2.40%
Biocon Ltd.
INE376G01013		Pharmaceuticals & Biotechnology2.31%
IPCA Laboratories Ltd.
INE571A01038		Pharmaceuticals & Biotechnology2.20%
Yatharth Hospital&Trauma Care Serv Ltd.
INE0JO301016		Healthcare Services2.16%
Rainbow Children's Medicare Ltd.
INE961O01016		Healthcare Services2.12%
Syngene International Ltd.
INE398R01022		Healthcare Services1.56%
Gujarat Fluorochemicals Ltd.
INE09N301011		Chemicals & Petrochemicals1.54%
Global Health Ltd.
INE474Q01031		Healthcare Services0.18%

Debt, money market and cash 2

HoldingSector / type% of fund
Treps–3.37%
Net Receivables / (Payables)–0.44%

From the fund house's monthly portfolio (licmf.com), as on 31 Oct 2026. Percentages are of the fund's net assets. Published about ten days after each month ends.

Risk

Volatility13.7%yearly, from daily NAVs
Worst fall-14.91%6 Dec 2024 → 28 Feb 2025
RiskometerVery HighVery High

Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 31 Jul 2023).

Fund details

Fund size (average AUM, July - September 2026)₹99.41 cr across all plans · this plan ₹13.45 cr
Fund houseLIC Mutual Fund
CategoryEquity · Sectoral / Thematic
PlanDirect
OptionGrowth
Expense ratio (TER)Direct 1.42% · Regular 2.72% (6 Nov 2026)
Exit loadNil, If units of the Scheme are redeemed or switched out up to 12% of the units (the limit) within 90 days from the date of allotment. 1% of the applicable NAV, If units of the scheme are redeemed or switched out in excess of the limit within 90 days from the date of allotment. Nil, If units of scheme are redeemed or switched out after 90 days from the date of allotment.
Minimum investment₹5,000 · additional ₹500
Scheme code (AMFI)152024
ISININF397L01LK4
NAV date6 Nov 2026

Scheme details from the fund's scheme summary document filed with AMFI; expense ratios from AMFI's daily filings.

Other plans of this fund

PlanNAV1 year
Direct · IDCW₹37.4152+14.31%
Regular · Growth₹33.7110+12.81%
Regular · IDCW₹33.7115+12.81%

Top Sectoral / Thematic funds (direct plans)

Fund1 year3 years (a year)
Nippon India Taiwan Equity Fund+39.55%+42.38%
HDFC Defence Fund+20.78%+35.14%
HDFC Pharma and Healthcare Fund+28.23%+31.72%
SBI HEALTHCARE OPPORTUNITIES FUND+22.32%+25.68%
HDFC Transportation and Logistics Fund+9.94%+25.29%
Mirae Asset Healthcare Fund+24.35%+25.21%
UTI - Healthcare Fund+18.81%+24.71%
ICICI PRUDENTIAL TRANSPORTATION AND LOGISTICS FUND+11.93%+23.21%
LIC MF Healthcare Fund+14.31%+22.81%

All Sectoral / Thematic funds ranked › · Compare with others ›

← All mutual funds

Information only, not investment advice.

What is the NAV of LIC MF Healthcare Fund - Direct Plan - Growth today?

₹37.4275 as of 6 Nov 2026, from AMFI's official NAV data.

What are the returns of LIC MF Healthcare Fund - Direct Plan - Growth?

1 year: 14.31%, 3 years: 22.81% a year

How does LIC MF Healthcare Fund rank in its category?

32 of 204 Sectoral / Thematic funds (direct plans, growth option) by 1-year return.

What is the difference between direct and regular plans?

Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.